Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIOPEL-3: Chemotherapy for Childhood Liver Cancer
NCT00003912Phase 3Completed
- Sponsor
- SIOP
- Start
- Jun 1998
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cisplatin, doxorubicin and carboplatin in hepatoblastoma and hepatocellular carcinoma (HCC) (3 arms), sponsored by SIOP. Primary endpoints: Tumor response, Complete resection rate and 3 more. Started Jun 1998; status: completed.
02
Drugs
cisplatindoxorubicincarboplatin
03
Conditions
hepatoblastomahepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00003912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003912.